Global Stem Cell Manufacturing Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Stem Cell Manufacturing Market Size Likely To Evolve From 2025 Through 2034?

The stem cell manufacturing market size has experienced robust expansion in recent years. It is projected to grow from $17.5 billion in 2024 to $19.17 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this growth can be attributed to advancements in biotechnology, various research and development initiatives, successful clinical trials and their therapeutic applications, the establishment of a regulatory framework, and significant investment in infrastructure.

The stem cell manufacturing market size is anticipated to experience substantial growth in the coming years. Its value is projected to reach $30.03 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.9%. This expansion during the forecast period can be attributed to several factors including increased funding and investments, the widening scope of therapeutic applications, the emergence of novel cell-based therapies, a rise in clinical trials and subsequent approvals, and the development of customized, patient-specific treatments. Significant trends expected during this period include a stronger emphasis on 3D bioprinting, the expansion and refinement of induced pluripotent stem cells (iPSCs), greater integration of automation and robotics, efforts towards standardization and scalability, and ongoing advancements in bioreactor technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp

Which Industry Drivers Are Expected To Accelerate The Stem Cell Manufacturing Market From 2025 To 2029?

An expanding geriatric population is anticipated to drive the stem cell manufacturing market. The geriatric population comprises older adults who are 65 years old and beyond. This demographic frequently experiences various diseases due to reduced immunity and advancing age. Aging elevates the risk of chronic diseases, and stem cell manufacturing can aid in addressing these conditions. For instance, in January 2024, data from the Population Reference Bureau, a Kenya-based Nonprofit organization, showed that the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the increasing geriatric population is propelling the growth of the stem cell manufacturing market.

What Are The Major Segment Categories Driving The Stem Cell Manufacturing Market Growth?

The stem cell manufacturingmarket covered in this report is segmented –

1) By Product: Consumables; Instruments; Stem Cell Lines

2) By Application: Research Applications; Clinical Application; Cell And Tissue Banking Applications

3) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes, Research Laboratories And Contract Research Organizations; Hospitals And Surgical Centers; Cell And Tissue Banks; Other End Users

Subsegments:

1) By Consumables: Media And Reagents; Cell Culture Vessels; Assay Kits

2) By Instruments: Bioreactors; Cell Counters; Flow Cytometers

3) By Stem Cell Lines: Embryonic Stem Cell Lines; Adult Stem Cell Lines; Induced Pluripotent Stem Cell Lines (iPSCs)

Which Key Trends Are Expected To Influence The Stem Cell Manufacturing Market In The Coming Years?

Technological advancement is a primary driver in the stem cell manufacturing market. Diverse entities in the market are prioritizing the adoption of advanced technologies to ensure their continued presence. For instance, in August 2022, Bluebird Bio Inc., a US-based biotechnology company, reported the U.S. Food and Drug Administration (FDA) approval for ZYNTEGLO. This product is a revolutionary one-time gene therapy now authorized for treating beta-thalassemia in patients who require regular red blood cell transfusions. A key element of this therapy is its ex-vivo method, which involves integrating a modified beta-globin gene into the patient’s own hematopoietic stem cells, enabling them to produce normal levels of hemoglobin. This cutting-edge treatment aims to establish transfusion independence, significantly reducing the treatment burden experienced by individuals with beta-thalassemia. The approval of ZYNTEGLO represents a significant achievement in the field of gene therapy, potentially offering a cure and improving the quality of life for those affected.

Who Are The Top Performing Companies In The Stem Cell Manufacturing Market In Recent Years?

Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

How Does The Stem Cell Manufacturing Market Perform Across Key Geographic Regions?

North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Stem Cell Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp

Browse Through More Reports Similar to the Global Stem Cell Manufacturing Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795